Drugs / C-84
C-84
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03531242 | Jun 2021 → Dec 2023 overdue | Venezuelan equine encephalitis | U.S. Army Medical Research and Development Command | Not yet recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | C-84 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03531242 ↗ |
| Known as | TSI-GSD 205 | “Venezuelan Equine Encephalomyelitis Vaccine, Inactivated, Dried, C-84, TSI-GSD 205, Lot 7, Run 1” NCT03531242 ↗ |
| Known as | Venezuelan Equine Encephalomyelitis Vaccine | “Venezuelan Equine Encephalomyelitis Vaccine, Inactivated, Dried, C-84, TSI-GSD 205, Lot 7, Run 1” NCT03531242 ↗ |
| Modality | Vaccine | “VEE vaccine, C-84” NCT03531242 ↗ |